Activity not yet confirmed Verified 5 Nov 2026
Longevity Funds 2
San Francisco venture fund started in 2011 by Laura Deming that backs companies developing drugs for longevity and age-related disease; the firm says it is launching a new fund under a new name (age1).
- Type
- VC firm
- Location
- San Francisco, California, United States
- Backs
- Biotech and pharma
- Sectors
- Biotech, Healthtech and life sciences
- Fund size / AUM
- $36M gross private fund assets (Form ADV; private funds: 2, of which venture capital: 2)
- Portfolio mix
- Biotech and pharma 91%; Medtech and digital health 9% (n=12)
- Website
- longevity.vc
Contacts on file
For Longevity Funds 2, the paid file holds: firm contact email (domain checked).
Get US Complete, $197 Free sample
One-time payment. No subscription. No account.
Notable investments
AnagenexArdatxConceptionDeciduoustxFaunabio
Sources
Last checked 5 Nov 2026. Is something wrong? Tell us.
Appears in 11 lists
Biotech investors in the San Francisco Bay Area (88)Biotech investors in California (108)Healthtech investors in the San Francisco Bay Area (182)Healthtech investors in California (240)Biotech venture capital firms in the US (297)Biotech investors (484)Healthtech venture capital firms in the US (709)Venture capital firms in the San Francisco Bay Area (768)Venture capital firms in California (1,038)Healthtech investors (1,207)Venture capital firms in the US (2,975)